Cargando…
Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancer
PURPOSE: Male breast cancer (MBC) is a rare cancer accounting for only 1% of all male cancers and is, therefore, poorly studied. We aimed to characterize the subtypes of MBC in Japanese patients based on genetic profiling, the presence of tumor-infiltrating cells, and the expression of immunohistoch...
Autores principales: | Shimomura, Akihiko, Yoshida, Masayuki, Kubo, Takashi, Yamashita, Satoshi, Noguchi, Emi, Nagayama, Aiko, Hanamura, Toru, Okazaki, Miki, Mukohara, Toru, Tsuruga, Asako, Tanaka, Kiyo, Kawamura, Yukino, Higuchi, Toru, Takahashi, Yoko, Kurozumi, Sasagu, Hayashida, Tetsu, Ichikawa, Hitoshi, Ushijima, Toshikazu, Suto, Akihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883318/ https://www.ncbi.nlm.nih.gov/pubmed/36494460 http://dx.doi.org/10.1007/s10549-022-06822-x |
Ejemplares similares
-
Is adjuvant chemotherapy necessary in older patients with breast cancer?
por: Morita, Midori, et al.
Publicado: (2022) -
Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment
por: Hanamura, Toru, et al.
Publicado: (2023) -
Correction: Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment
por: Hanamura, Toru, et al.
Publicado: (2023) -
Role of HER2-Targeted Agents in Adjuvant Treatment for Breast Cancer
por: Mukohara, Toru
Publicado: (2011) -
PI3K mutations in breast cancer: prognostic and therapeutic implications
por: Mukohara, Toru
Publicado: (2015)